By Rishika Sadam and Sriparna Roy
HYDERABAD, Feb 17 (Reuters) – Indian drugmaker Dr Reddy’s laboratories aims to launch a generic version of Novo Nordisk’s blockbuster weight loss drug Wegovy, subject to approval, at a price about 60% lower than the branded version, co-chairman and managing director GV Prasad told Reuters on Tuesday.
The company last month received an approval from India’s drug regulator to manufacture and sell the generic version of blockbuster diabetes drug Ozempic and said it was awaiting approval for Wegovy.
(Reporting by Rishika Sadam and Sriparna Roy in Hyderabad)
Comments